Total Knee Arthroplasty and Parkinson Disease: Enhancing Outcomes and Avoiding Complications - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

Total Knee Arthroplasty and Parkinson Disease: Enhancing Outcomes and Avoiding Complications

Description:

Total Knee Arthroplasty and Parkinson Disease: Enhancing Outcomes and Avoiding Complications Macaulay W, Geller JA, Brown AR, Cote LJ, Kiernan HA – PowerPoint PPT presentation

Number of Views:147
Avg rating:3.0/5.0
Slides: 19
Provided by: StewartM6
Category:

less

Transcript and Presenter's Notes

Title: Total Knee Arthroplasty and Parkinson Disease: Enhancing Outcomes and Avoiding Complications


1
Total Knee Arthroplasty and Parkinson Disease
Enhancing Outcomes and Avoiding Complications
  • Macaulay W, Geller JA, Brown AR, Cote LJ, Kiernan
    HA

2
Introduction I
  • PD is the second most common neurodegenerative
    disorder after Alzheimer disease
  • USA Australia World
  • 0.3 population
  • 1-2 persons 65 yrs 3-6-4.9 1.8
  • 4-5 persons gt 85 yrs 2.6
  • TKR outcome has proved a challenge in PD
  • Musculoskeletal Rigidity
  • Tremor
  • Contracture
  • Gait Instability

Chan DK, Dunne M, Wong A, Hu E, Hung WT Beran
RG 2001. Pilot study of prevalence of Parkinsons
disease in Australia. Neuroepidemiology 20
112-7 de Rijk MC et al (2000). Prevalence of
Parkinsons disease in Europe a collaborative
study of population-based cohorts. Neurology
54(Suppl)
3
Introduction II
  • integrative, systematic, multidisciplinary
    approach to patients with PD undergoing TKR
  • the lack of evidence-based medicine and overall
    paucity of published studies severely limits
    review of this topic.

4
Parkinson Disease Pathophysiology
  • Idiopathic
  • Secondary medications, toxins, environmental
    factors
  • herbicide/ pesticide/ chemical exposure, FHx,
    smoking, tea drinking, high cholesterol
  • Disease optimisation can be difficult due to
    idiopathic nature.
  • Loss of dopaminergic neurons in the substantia
    nigra
  • no dopamine
  • no regulation of excitatory and inhibitory
    outflow from basal ganglia
  • disturbance of motor pathways

5
Parkinson Disease Severity Rating Scales
  • Unified Parkinsons Disease Rating Scale
    mentation, behaviour, mood, motor ability, ADLs,
    therapy complications
  • Schwab and England Scale
  • Modified Hoehn and Yahr Scale

6
(No Transcript)
7
TKA and Parkinson Disease
  • TKR is less successful in PD than in typical
    patients with OA
  • Oni MacKenny (1985)
  • 3 patients, 2 ruptured quadriceps tendons, all
    died within 24 weeks.
  • Vince et al. (1989)
  • 9 patients, 13 TKRs, 4.3 yr follow up, all HK
    1-3.
  • Duffy Trousedale (1996)
  • 24 patients, 33 TKRs, 33 month follow up,
    achieved pain relief but not functional status
  • Erceg Maricevic (2000)
  • Case report, recurrent posterior dislocation
    requiring revision
  • Shah et al. (2005)
  • Case report, diabetic coma, UTI, recalcitrant
    flexion contracture, 2200 U botulinum toxin type
    A into biceps femoris and semitendinosis, and
    subsequently gastrocnaemius, with greatly
    increased ROM

8
TKA and Parkinson Disease
  • Recurring Themes
  • Extensor mechanism problems
  • Wound necrosis
  • Post-operative confusion
  • Limited functional improvement

9
Avoiding Early Complications
  • Difficult to conclude whether PD is a
    contraindication to TKR.
  • Achieving pain relief while minimising
    perioperative complications, may be the target
    goal.
  • Multimodal approach required
  • Patients expectations and goals need to be
    clearly established

10
Medical Management I
  • Decreased function may be as a result of OA, or
    PD
  • This may be more appropriately addressed with
    physical therapy and botox
  • TKR should be considered only after failure of
    these measures, and presence of debilitating
    joint pain.
  • Perioperative plan from patients neurologist
    regarding recommencement of PD medications

11
Medical Management II
  • Mehta et al report that neurological intervention
    preoperatively, or on day of surgery, was the key
    to a good clinical outcome after TKR.
  • immediate rather than delayed consultation with
    neurologist perform better (LOS, KS Scores)
  • Triggers required for repeat consultation
  • change in mentation, deterioration in
    neurological status, pharmacological management
  • Intraoperative anaesthesia and post-operative
    analgesia
  • regional preferable to general anaesthesia
    (particularly in pts with ongoing
    levodopa/carbidopa therapy)
  • general anaesthesia has been shown to mask
    myopotentials and PD symptoms
  • Opiod drugs effect dopaminergic pathway, and
    hence mental state and Parkinsonian symptoms

12
Medical Management III
  • Ketorolac 15 to 30 mg Intramuscularly Q6H for 48
    hrs
  • Perioperative risks may outweigh benefits for pts
    no able to tolerate regional anaesthesia or
    non-opiod analgesics
  • Interactions between analgesics and patients
    medications should be addressed.
  • Almost no data available in the literature.
  • PD patients have a high risk of falls, and hence
    nursing vigilance is recommended.

13
Orthopaedic Management
  • CR and PS prostheses mild disease, normal
    quadriceps and hamstrings function
  • Authors prefer CR, condylar-constrained, or
    hinged prostheses, due to the incidence of
    subluxation of PS components
  • Hinged prostheses may be the safest option in
    patients with severe disease.
  • Activity levels of these patients mitigate the
    concerns of using a fully constrained prosthesis
  • Authors recommendation based on severity of
    flexion deformity and rigidity

14
Orthopaedic Management II
  • No literature recommending particularly surgical
    approach
  • Pt should be assessed regularly for
  • Surgical site infection
  • Intact extensor mechanism
  • Flexion contracture serial bracing, splinting,
    casting, (No evidence for CPM)
  • Patellar maltracking
  • Sialorrhea (PD patients higher risk for silent
    aspiration)

15
Orthopaedic Management II
  • Seyler et al described the use of botulinum toxin
    type A to improve flexion contractures following
    TKR
  • improved and sustained ROM in 9/11 knees at 2
    year follow up
  • Orthopaedic/Neurology communication should
    continue post-discharge

16
Summary I
  • Limited data to aid and predict outcome following
    TKR in PD patients

17
Summary II
  • Recommendations for TKA
  • Only perform TKA after failure of nonsurgical
    measures and in the presence of debilitating
    joint pain
  • Use cruciate-retaining, condylar constrained
    kinetic, or hinged-knee devices in patients with
    severe PD
  • Do not use isolated femoral blockade, which may
    potentiate the early development of postoperative
    flexion contracture
  • Use sciatic blockade or hamstring botulinum toxin
    type A injection
  • Do not use CPM
  • Use extremely well-padded braces, splints, or
    casts in full extension
  • Contraindications to TKA
  • Any level of preoperative delirium
  • Patient is not a candidate for regional
    anesthesia or it is not achievable (ie, due to
    body habitus) and general anesthesia is the only
    option
  • Opiates required postoperatively
  • Multidisciplinary team members are not available
    (ie, orthopaedic staff, neurologist, pain service
    staff, highly trained nursing staff, geriatrics
    specialists, physiatrist)
  • Hoehn and Yahr rating 3
  • Preoperative knee flexion contracture gt25
  • No response to preoperative diagnostic
    bupivacaine hydrochloride injection

18
Thank you
Write a Comment
User Comments (0)
About PowerShow.com